Press Releases

Date Title View
Toggle Summary Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company
LOS ANGELES --(BUSINESS WIRE)--Apr. 9, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Appoints John T. Blake Chief Financial Officer
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 22, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Appoints Gregg Williams as Chairman of the Board of Directors
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 16, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 8, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results
-- Year-over-year net sales in 2017 double to $8 million , driven by record implant volume -- SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 7, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual
View HTML
Toggle Summary Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System
-- Argus II Covered in Majority of Medicare Administrative Contractor Jurisdictions Across 31 States -- SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 6, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual
View HTML
Toggle Summary Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018
SYLMAR, Calif. --(BUSINESS WIRE)--Mar. 5, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML
Toggle Summary Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)--Feb. 28, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, will release its fourth quarter and
View HTML
Toggle Summary Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System
SYLMAR, Calif. --(BUSINESS WIRE)--Feb. 16, 2018-- Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind patients, today
View HTML
Toggle Summary Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant
SYLMAR, Calif. --(BUSINESS WIRE)--Feb. 5, 2018-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind patients, today
View HTML